2006
DOI: 10.1016/j.bbrc.2006.10.043
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
36
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 45 publications
(39 citation statements)
references
References 26 publications
3
36
0
Order By: Relevance
“…In contrast, NSC23766 had little effect on the survival of the MCF12A normal mammary epithelial cells. Consistent with previous reports (36,41), NSC23766 selectively inhibited Rac1 activation without interfering with the activity of the closely related small GTPase Cdc42 in MDA-MB-231 (Fig. 1B) and other cell lines (data not shown).…”
Section: Resultssupporting
confidence: 92%
See 1 more Smart Citation
“…In contrast, NSC23766 had little effect on the survival of the MCF12A normal mammary epithelial cells. Consistent with previous reports (36,41), NSC23766 selectively inhibited Rac1 activation without interfering with the activity of the closely related small GTPase Cdc42 in MDA-MB-231 (Fig. 1B) and other cell lines (data not shown).…”
Section: Resultssupporting
confidence: 92%
“…36). Repression of Rac1 activity by NSC23766 diminished Rac-dependent cell proliferation of PC3 prostate cancer line (36) and leukemia cell lines both in vitro and in vivo (37)(38)(39)(40); it also inhibited cell migration of several breast cancer cell lines (41) and induced apoptosis in leukemia (37)(38)(39)(40) and glioma (42) cell lines. Increasing evidence shows that Tiam1 and Trio are overexpressed in different types of human tumors (18)(19)(20), including human breast (42) carcinomas, which is believed to contribute to Rac1 hyperactivity.…”
Section: Introductionmentioning
confidence: 98%
“…4B) demonstrated that hESCs pretreated with 100 M Y27632 displayed a Ϸ2-fold increase in wound closure compared with control untreated hESCs. In contrast, and as shown for other cell types (20), inhibition of Rac1 signaling with the Rac1 inhibitor, NSC23766 (21) resulted in a significant decrease in cell motility (Fig. 4 C and D).…”
Section: Inhibition Of Rho-kinase Signaling In Hescs Increases Trophosupporting
confidence: 73%
“…For example, inhibition of Rac1 blocks migration in some breast cancer lines, but stimulates it in others (Zuo et al, 2006). Within a single cell line, Rac activation can increase or decrease migration, depending on the substrate (Sander et al, 1998).…”
Section: Context-dependent and Paradoxical Functionsmentioning
confidence: 99%